MSCOP
MSCOP
Stem cell therapy for osteoporosis (bone loss) using Mesenchymal Stem Cells (MSCs)a high-potential treatment for restoring bone strength and slowing degeneration.
The Hidden Dangers of Osteoporosis
Over 90 million people affected in China, with rapid growth across Asia
Leads to chronic pain, limited mobility, and bone fractures from minor impacts
Reduces quality of life and increases mortality risk in the elderly
How MSCOP Works
Osteogenesis Promotion (Bone Formation):
- Stimulates the body to produce more osteoblasts (bone-forming cells)
- Enhances bone cell activity through signaling from nearby cells
Homing Effect
MSCs travel directly to areas of bone thinning or damage and repair them locally
Immunomodulation Regulates immune activity to reduce excessive bone loss
Proven Research & Trials
- Animal trials in osteoporotic rats (via ovary removal and retinoic acid induction)
- Clear improvements in Bone Mineral Density (BMD) at femur and cervical spine
- Currently undergoing human trials if confirmed safe, it will be a promising treatment
Interested in Cell Therapy Technology?
Contact our team for consultation on personalized treatment, clinical research, or innovative health product development using cell therapy.
Compare product
0/4
Remove all
Powered By
MakeWebEasy
MakeWebEasy